Trial watch: Peptide-based vaccines in anticancer therapy

Author:

Bezu Lucillia12345ORCID,Kepp Oliver23456ORCID,Cerrato Giulia23456,Pol Jonathan23456,Fucikova Jitka78,Spisek Radek78,Zitvogel Laurence1910,Kroemer Guido23456ORCID,Galluzzi Lorenzo51112

Affiliation:

1. Faculty of Medicine, University of Paris Sud/Paris XI, Le Kremlin-Bicêtre, France

2. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France

3. Equipe 11 labellisée Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers,Paris, France

4. U1138, INSERM, Paris, France

5. Université Paris Descartes/Paris V, Paris, France

6. Université Pierre et Marie Curie/Paris VI, Paris, France

7. Sotio, Prague, Czech Republic

8. Dept. of Immunology, 2nd Faculty of Medicine and University Hospital Motol, Charles University, Prague, Czech Republic

9. Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France

10. INSERM, U1015, Gustave Roussy Cancer Campus, Villejuif, France

11. Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA

12. Sandra and Edward Meyer Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3